We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3382:TSESeven & I Holdings Co., Ltd. Analysis

Data as of 2026-03-10 - not real-time

¥2,055.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Seven & i Holdings trades around ¥2,055, well above its DCF‑derived fair value of roughly ¥1,240, suggesting the market is pricing in optimism despite a 20% revenue contraction and a hefty debt‑to‑equity ratio of 104%. The stock’s technical profile is mixed: RSI sits at 36, hinting at near‑oversold conditions, while the MACD remains bearish and the 20‑day SMA (¥2,203) sits above the current price, reinforcing a neutral‑to‑downward bias. Recent earnings releases show a striking 324% YoY EPS jump and a 3.1% rise in operating income, beating consensus forecasts and fueling short‑term enthusiasm. However, free cash flow is negative and leverage is high, raising questions about the sustainability of the 2.42% dividend (payout ~48%).
The defensive grocery sector generally offers low‑volatility exposure (beta ~0.13, 30‑day volatility 27.8%), but Seven & i’s international footprint adds medium geographic risk and modest currency exposure. Valuation metrics (PE 21.8x, forward PE 17.8x) appear stretched relative to earnings growth, and the “Extreme Greed” sentiment index (78.8) may be over‑optimistic. In sum, the stock shows short‑term upside potential from earnings momentum but faces longer‑term headwinds from weak cash generation, high debt, and an overvalued price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and 324% EPS surge
  • RSI near oversold levels offering bounce potential
  • Bearish MACD and price below 20‑day SMA limiting upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Current price above DCF fair value indicating overvaluation
  • Revenue decline and high leverage constraining growth
  • Stable dividend yield but questionable cash sustainability

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Persistent revenue contraction and negative free cash flow
  • Debt‑to‑equity over 100% raising solvency concerns
  • Valuation metrics remain stretched relative to fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth-20.70%
Profit Margin3.29%
P/E Ratio21.8
ROE8.58%
ROA2.72%
Debt/Equity104.41
P/B Ratio1.4
Op. Cash Flow¥609.0B
Free Cash Flow¥-464384262144

Technical Analysis

TrendNeutral
RSI36.5
Support¥1,981.00
Resistance¥2,417.00
MA 20¥2,203.00
MA 50¥2,229.18
MA 200¥2,117.84
MACDBearish
VolumeIncreasing
Fear & Greed Index78.79

Valuation

Fair Value¥1,238.81
Target Price¥2,460.67
Upside/Downside19.74%
GradeOvervalued
TypeBlend
Dividend Yield2.42%

Risk Assessment

Beta0.40
Volatility27.76%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.